Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.500
+0.060 (1.74%)
At close: Feb 10, 2026
Scandinavian ChemoTech AB Company Description
Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally.
It operates in two divisions, Human Care and Animal Care. The company offers IQWave, an electroporation that generates a tumour-specific electrical stimulation; and veterinary medicines under the vetIQur name.
Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
Scandinavian ChemoTech AB (publ)
| Country | Sweden |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Stefan Frick |
Contact Details
Address: Medicon Village Lund, 223 63 Sweden | |
| Phone | 46 10 218 93 00 |
| Website | chemotech.se |
Stock Details
| Ticker Symbol | CMOTEC.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009242654 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stefan Mohan Frick | Founder, Chief Executive Officer, President and Director |
| Ann Ohlsson | Head of Finance |